Currenc Group Inc. Ordinary Shares (CURR)vsZepp Health Corp (ZEPP)
CURR
Currenc Group Inc. Ordinary Shares
$3.56
+6.27%
TECHNOLOGY · Cap: $242.86M
ZEPP
Zepp Health Corp
$17.47
+4.55%
TECHNOLOGY · Cap: $247.54M
Smart Verdict
WallStSmart Research — data-driven comparison
Zepp Health Corp generates 544% more annual revenue ($258.90M vs $40.23M). ZEPP leads profitability with a -15.5% profit margin vs -84.7%. ZEPP earns a higher WallStSmart Score of 41/100 (D).
CURR
Avoid23
out of 100
Grade: F
ZEPP
Hold41
out of 100
Grade: D
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+17.7%
Fair Value
$2.43
Current Price
$3.56
$1.13 discount
Margin of Safety
+48.6%
Fair Value
$46.70
Current Price
$17.47
$29.23 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Strong operational efficiency at 45.8%
Reasonable price relative to book value
Revenue surging 43.0% year-over-year
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
ROE of -3504.0% — below average capital efficiency
Revenue declined 7.7%
Smaller company, higher risk/reward
ROE of -17.2% — below average capital efficiency
Earnings declined 68.1%
Currently unprofitable
Comparative Analysis Report
WallStSmart ResearchBull Case : CURR
The strongest argument for CURR centers on Operating Margin.
Bull Case : ZEPP
The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.
Bear Case : CURR
The primary concerns for CURR are EPS Growth, Market Cap, Return on Equity.
Bear Case : ZEPP
The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.
Key Dynamics to Monitor
CURR profiles as a turnaround stock while ZEPP is a hypergrowth play — different risk/reward profiles.
ZEPP carries more volatility with a beta of 1.77 — expect wider price swings.
ZEPP is growing revenue faster at 43.0% — sustainability is the question.
Monitor SOFTWARE - APPLICATION industry trends, competitive dynamics, and regulatory changes.
Bottom Line
ZEPP scores higher overall (41/100 vs 23/100) and 43.0% revenue growth. CURR offers better value entry with a 17.7% margin of safety. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Currenc Group Inc. Ordinary Shares
TECHNOLOGY · SOFTWARE - APPLICATION · USA
Avenir Wellness Solutions, Inc., through its subsidiary The Sera Labs, Inc., engages in the development of nutraceutical formulation and delivery technologies in novel dosage forms to improve efficacy and enhance wellness. The company is headquartered in Sherman Oaks, California.
Zepp Health Corp
TECHNOLOGY · CONSUMER ELECTRONICS · China
Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.
Compare with Other SOFTWARE - APPLICATION Stocks
Want to dig deeper into these stocks?